Page last updated: 2024-10-26

erythrosine and Astrocytoma, Grade IV

erythrosine has been researched along with Astrocytoma, Grade IV in 14 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Research Excerpts

ExcerptRelevanceReference
" Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ)."7.81Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. ( Munoz, JL; Rameshwar, P; Scotto, KW; Walker, ND, 2015)
" Therefore, we studied the effects of the new monastrol analogues enastron, dimethylenastron and vasastrol VS-83 on the proliferation of human glioblastoma cells in the kinetic crystal violet assay."7.74Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells. ( Bernhardt, G; Buschauer, A; Gartner, M; Giannis, A; Gross, D; Müller, C; Sarli, V, 2007)
"Total resection is the optimal treatment for malignant gliomas."5.30Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. ( Ishii, H; Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Takeuchi, H, 1997)
"Solid lipid nanoparticles (SLNs) conjugated with tamoxifen (TX) and lactoferrin (Lf) were applied to carry anticancer carmustine (BCNU) across the blood-brain barrier (BBB) for enhanced antiproliferation against glioblastoma multiforme (GBM)."3.83Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation. ( Cheng, SJ; Kuo, YC, 2016)
" Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ)."3.81Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. ( Munoz, JL; Rameshwar, P; Scotto, KW; Walker, ND, 2015)
" Therefore, we studied the effects of the new monastrol analogues enastron, dimethylenastron and vasastrol VS-83 on the proliferation of human glioblastoma cells in the kinetic crystal violet assay."3.74Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells. ( Bernhardt, G; Buschauer, A; Gartner, M; Giannis, A; Gross, D; Müller, C; Sarli, V, 2007)
"Total resection is the optimal treatment for malignant gliomas."1.30Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. ( Ishii, H; Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Takeuchi, H, 1997)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19902 (14.29)18.7374
1990's1 (7.14)18.2507
2000's2 (14.29)29.6817
2010's8 (57.14)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Ozden, M1
Mammadkhanli, O1
Zaimoglu, M1
Bayatli, E1
Bozkurt, M1
Azari, H3
Deleyrolle, LP3
Reynolds, BA3
Nakazawa, T1
Nakamura, M1
Park, YS1
Motoyama, Y1
Hironaka, Y1
Nishimura, F1
Nakagawa, I1
Yamada, S1
Matsuda, R1
Tamura, K1
Sugimoto, T1
Takeshima, Y1
Marutani, A1
Tsujimura, T1
Ouji, N1
Ouji, Y1
Yoshikawa, M1
Nakase, H1
Munoz, JL1
Walker, ND1
Scotto, KW1
Rameshwar, P1
Kuo, YC1
Cheng, SJ1
Ning, D1
Duong, B1
Thomas, G1
Qiao, Y1
Ma, L1
Wen, Q1
Su, M1
Kremer, P1
Fardanesh, M1
Ding, R1
Pritsch, M1
Zoubaa, S1
Frei, E1
Harding, A1
Cato, K1
Siebzehnrubl, FA1
Rahman, M1
Olson, S1
Gabrielli, B1
Osborne, G1
Vescovi, A1
Murayama, H1
Sadakane, K1
Yamanoha, B1
Kogure, S1
Rohaus, MR1
Fortin, JM1
Müller, C1
Gross, D1
Sarli, V1
Gartner, M1
Giannis, A1
Bernhardt, G1
Buschauer, A1
Kabuto, M1
Kubota, T1
Kobayashi, H1
Nakagawa, T1
Ishii, H1
Takeuchi, H1
Kitai, R1
Kodera, T1
Kawase, T1
Ginsbourg, M1
Foncin, JF1
Le Beau, J1

Other Studies

14 other studies available for erythrosine and Astrocytoma, Grade IV

ArticleYear
Could Fluorescein Staining in Low-Grade Glial Tumors Guide for Peroperative Differentiation of Pathological Types?
    Turkish neurosurgery, 2023, Volume: 33, Issue:5

    Topics: Astrocytoma; Brain Neoplasms; Fluoresceins; Glioblastoma; Glioma; Humans; Oligodendroglioma; Retrosp

2023
Using Carboxy Fluorescein Succinimidyl Ester (CFSE) to Identify Quiescent Glioblastoma Stem-Like Cells.
    Methods in molecular biology (Clifton, N.J.), 2018, Volume: 1686

    Topics: Cell Division; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glioblastoma; Humans; Neoplastic Stem

2018
Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.
    Journal of neuro-oncology, 2014, Volume: 116, Issue:1

    Topics: Analysis of Variance; Antigens, CD; Bone Density Conservation Agents; Cell Line, Tumor; Diphosphonat

2014
Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells.
    Cancer letters, 2015, Oct-10, Volume: 367, Issue:1

    Topics: Animals; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; Binding,

2015
Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    International journal of pharmaceutics, 2016, Feb-29, Volume: 499, Issue:1-2

    Topics: Antineoplastic Agents; Astrocytes; Blood-Brain Barrier; Brain; Carmustine; Cell Line, Tumor; Delayed

2016
Mechanical and Morphological Analysis of Cancer Cells on Nanostructured Substrates.
    Langmuir : the ACS journal of surfaces and colloids, 2016, Mar-22, Volume: 32, Issue:11

    Topics: Acrylic Resins; Actins; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival;

2016
Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin.
    Neurosurgery, 2009, Volume: 64, Issue:3 Suppl

    Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Female; Fluoresceins; Glioblastoma; Glioma; Humans

2009
Evidence for label-retaining tumour-initiating cells in human glioblastoma.
    Brain : a journal of neurology, 2011, Volume: 134, Issue:Pt 5

    Topics: Animals; Antigens, CD; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Differenti

2011
Low-power 808-nm laser irradiation inhibits cell proliferation of a human-derived glioblastoma cell line in vitro.
    Lasers in medical science, 2012, Volume: 27, Issue:1

    Topics: Bromodeoxyuridine; Cell Count; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasm

2012
Identification and isolation of slow-dividing cells in human glioblastoma using carboxy fluorescein succinimidyl ester (CFSE).
    Journal of visualized experiments : JoVE, 2012, Apr-29, Issue:62

    Topics: Brain Neoplasms; Cell Growth Processes; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glioblastoma

2012
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
    Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:2

    Topics: Acridines; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member

2007
Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration.
    Neurological research, 1997, Volume: 19, Issue:1

    Topics: Animals; Astrocytoma; Brain Neoplasms; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Glioblas

1997
[Study of cerebral microcirculation by serial fluorescein cortical angiography. (Part 2) Pathology and classification of microcirculation].
    No to shinkei = Brain and nerve, 1977, Volume: 29, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluoresceins; Glioblastoma; Gliom

1977
[Vascular abnormalities in cerebral tumours. A comparative study of enzyme activity and permeability to fluorescent tracers].
    Revue neurologique, 1973, Volume: 129, Issue:5

    Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms;

1973